Karuna Therapeutics Inc (DELISTED) (KRTX:DL)
329.83
0.00 (0.00%)
USD |
NASDAQ |
Mar 18, 16:00
Karuna Therapeutics Free Cash Flow: -388.74M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -388.74M |
September 30, 2023 | -355.92M |
June 30, 2023 | -305.42M |
March 31, 2023 | -280.46M |
December 31, 2022 | -228.92M |
September 30, 2022 | -157.64M |
June 30, 2022 | -142.85M |
March 31, 2022 | -132.53M |
December 31, 2021 | -103.95M |
September 30, 2021 | -119.21M |
June 30, 2021 | -96.77M |
Date | Value |
---|---|
March 31, 2021 | -83.08M |
December 31, 2020 | -70.28M |
September 30, 2020 | -54.11M |
June 30, 2020 | -39.64M |
March 31, 2020 | -33.32M |
December 31, 2019 | -31.04M |
September 30, 2019 | -30.97M |
June 30, 2019 | -24.68M |
March 31, 2019 | -20.79M |
December 31, 2018 | -15.38M |
Free Cash Flow Range, Past 5 Years
-388.74M
Minimum
Dec 2023
-24.68M
Maximum
Jun 2019
-141.03M
Average
-103.95M
Median
Dec 2021
Free Cash Flow Benchmarks
Bristol-Myers Squibb Co | 12.51B |
RayzeBio inc (DELISTED) | -- |
Icosavax Inc (DELISTED) | -76.31M |
Madrigal Pharmaceuticals Inc | -325.71M |
Theseus Pharmaceuticals Inc (DELISTED) | -49.70M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -111.06M |
Cash from Investing (Quarterly) | 92.44M |
Cash from Financing (Quarterly) | 19.87M |
Free Cash Flow Per Share (Quarterly) | -2.96 |
Free Cash Flow Yield | -3.19% |